Abstract
Background There is an urgent need for a vaccine with efficacy against SARS-CoV-2. We hypothesize that peptide vaccines containing epitope regions optimized for concurrent B cell, CD4+ T cell, and...
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have